GO:0035633 maintenance of blood-brain barrier: Barrier Homeostasis, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0035633 (maintenance of blood-brain barrier) describes the biological process that preserves the structure and regulated transport function of the blood-brain barrier (BBB) after it has formed.
• The BBB is a dynamic, multi-cellular interface built from brain microvascular endothelial cells, pericytes, astrocyte end-feet, and a specialized basement membrane, supported by tight junction and transporter systems.
• Maintenance is not passive: it requires continuous signaling from pericytes, astrocytes, microglia, and the extracellular matrix, plus regulated trafficking of ions, macromolecules, and small molecules.
• Loss of BBB maintenance is a shared feature of Alzheimer's disease, stroke, multiple sclerosis, brain tumors, and sepsis-associated encephalopathy.
• Microglia are largely dispensable for steady-state BBB maintenance in health, but microglial manipulation can alter brain endothelial cholesterol metabolism, showing that maintenance is tunable.
• CRISPR knockout, point-mutation, knock-in, and overexpression models, combined with library screening and bioinformatics, are powerful tools to dissect causal genes in BBB maintenance.
Description
The blood-brain barrier (BBB) is a selective interface that separates the central nervous system (CNS) from the systemic circulation and tightly controls the exchange of ions, nutrients, macromolecules, and cells. Once the BBB is established during development, it must be actively maintained throughout life; this ongoing process is captured by the Gene Ontology term GO:0035633, maintenance of blood-brain barrier. The term refers to the preservation of both the structural integrity and the regulated transport functions of the BBB, ensuring that substances move into and out of the brain in a controlled manner. Maintenance of the BBB is essential for neuronal homeostasis, synaptic function, and immune privilege of the CNS. Disruption of this process is an early and often causal event in neurological disease, including Alzheimer's disease, multiple sclerosis, stroke, and brain tumors. Because BBB maintenance is orchestrated by multiple cell types and signaling pathways, it is a rich area for genetic and pharmacological interrogation. For researchers, GO:0035633 provides a precise framework to study how endothelial cells, pericytes, astrocytes, microglia, and the extracellular matrix cooperate to keep the barrier intact. Understanding the molecular players that maintain the BBB is a prerequisite for developing therapies that protect the barrier or transiently open it for drug delivery.
maintenance of blood-brain barrier At A Glance
| GO ID | GO:0035633 |
|---|---|
| GO term | maintenance of blood-brain barrier |
| Ontology | biological_process |
| Synonym | maintenance of BBB; maintenance of blood/brain barrier |
| Major function | Preserves BBB structure and regulated transport of macromolecules, small molecules, and ions into and out of the brain |
| Cellular participants | Brain microvascular endothelial cells, pericytes, astrocytes, microglia, basement membrane |
| Key structural features | Tight junctions, adherens junctions, transporter systems, efflux pumps, metabolic enzymes |
| Disease relevance | Alzheimer's disease, multiple sclerosis, stroke, brain tumors, sepsis-associated encephalopathy |
| Research tools | CRISPR KO/point mutation/knock-in/overexpression, library screening, bioinformatics |
What Is GO:0035633?
In our own words, GO:0035633 maintenance of blood-brain barrier is the biological process that keeps the blood-brain barrier structurally sound and functionally selective over time. It encompasses the continued operation of tight junctions, adherens junctions, transporter systems, and metabolic barriers that together ensure specific, regulated transport of macromolecules, small molecules, and ions from blood into the brain and from the brain back into the circulation. This process is distinct from BBB development or formation; it focuses on preserving an already established barrier.
Why Is maintenance of blood-brain barrier Important in Cell Biology?
Maintenance of the blood-brain barrier is fundamental to CNS health because it protects neurons from blood-derived toxins, pathogens, and immune cells while supplying essential nutrients and clearing waste. When this maintenance fails, the resulting barrier leakage contributes to neuroinflammation, synaptic dysfunction, and neurodegeneration, making GO:0035633 a central process in the pathophysiology of many neurological disorders. Moreover, the BBB is a major obstacle to drug delivery to the brain, so understanding its maintenance mechanisms is critical for designing strategies to transiently and safely modulate barrier permeability.
• Maintains CNS homeostasis by regulating ion, nutrient, and macromolecule flux across the BBB.
• Protects the brain from blood-borne toxins, pathogens, and peripheral immune cells.
• Preserves immune privilege of the CNS, limiting inappropriate neuroinflammation.
• Its failure is an early event in Alzheimer's disease and contributes to cognitive decline.
• BBB breakdown after stroke and in multiple sclerosis exacerbates tissue damage.
• Brain tumors such as glioblastoma disrupt BBB maintenance to support growth and invasion.
• Microglia and the gut-brain axis can modulate BBB maintenance, linking peripheral signals to CNS barrier function.
• Understanding maintenance mechanisms informs drug delivery strategies that transiently open the BBB.
• Genetic models of BBB maintenance genes help identify causal pathways and therapeutic targets.
• BBB maintenance is a prerequisite for neural stem cell niches and adult neurogenesis.
What Happens During maintenance of blood-brain barrier?
Tight junction and adherens junction turnover
In simple terms: The barrier's sealing proteins are constantly checked and replaced to keep the barrier tight.
Maintenance of the BBB requires continuous turnover and stabilization of tight junction proteins such as claudins, occludin, and junctional adhesion molecules, as well as adherens junction components like VE-cadherin. These junctions restrict paracellular diffusion and are linked to the actin cytoskeleton, allowing dynamic regulation in response to physiological and pathological signals. Disruption of junctional complexes is a hallmark of BBB breakdown in disease.
Transporter and efflux pump regulation
In simple terms: Pumps and transporters on brain endothelial cells decide which molecules enter or leave the brain.
The BBB expresses a wide array of influx and efflux transporters, including GLUT1, LAT1, P-glycoprotein, and BCRP, that maintain the brain's molecular environment. Maintenance of the BBB involves keeping these transporters correctly localized and functional, ensuring selective uptake of nutrients and exclusion of xenobiotics. Altered transporter expression or localization is observed in neurodegeneration and epilepsy.
Pericyte and astrocyte support
In simple terms: Support cells wrap around brain capillaries and send signals that keep the barrier healthy.
Pericytes embedded in the basement membrane and astrocyte end-feet ensheathing the capillaries provide trophic and structural support that is essential for BBB maintenance. Pericyte loss is associated with BBB breakdown and cognitive decline, while astrocyte-derived factors regulate junctional protein expression and transporter function. Signaling between endothelial cells, pericytes, and astrocytes is therefore a core component of GO:0035633.
Extracellular matrix and basement membrane remodeling
In simple terms: The scaffold around brain vessels is continually remodeled to support the barrier.
The basement membrane, composed of laminins, collagen IV, fibronectin, and proteoglycans, anchors endothelial cells, pericytes, and astrocytes and influences BBB integrity. Maintenance of the BBB includes regulated matrix remodeling by metalloproteinases and their inhibitors; excessive MMP activity degrades the basement membrane and increases permeability. Matrix-derived signals also modulate endothelial gene expression and junctional stability.
Immune and inflammatory surveillance
In simple terms: Immune cells and inflammatory signals are kept in check to avoid damaging the barrier.
Microglia and perivascular macrophages survey the CNS vasculature and can influence BBB properties. Under homeostatic conditions, microglia are not strictly required for BBB maintenance, but their manipulation can alter brain endothelial cholesterol metabolism, indicating a modulatory role. Inflammatory cytokines such as TNF-alpha and IL-1beta can disrupt junctional proteins and transporter function, so maintenance involves active suppression of inappropriate inflammation.
Gut-brain axis and systemic influences
In simple terms: Signals from the gut and the rest of the body can reach the brain barrier and affect its health.
The microbiota-gut-brain axis influences BBB maintenance through microbial metabolites, immune signaling, and lymphatic pathways. Systemic inflammation, metabolic disease, and aging can compromise BBB integrity, highlighting that maintenance is sensitive to peripheral physiology. These systemic inputs are increasingly recognized as modulators of GO:0035633.
Key Genes Involved in GO:0035633 maintenance of blood-brain barrier
The following genes and proteins are central to the maintenance of the blood-brain barrier (GO:0035633) based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CLDN5 | Tight junction protein forming the paracellular seal | Knockout causes BBB leakage; target for barrier modulation |
| OCLN | Tight junction protein contributing to barrier integrity | Regulated by inflammatory signals; studied in BBB breakdown |
| TJP1 (ZO-1) | Scaffolding protein linking tight junctions to actin | Essential for junctional assembly and maintenance |
| CDH5 (VE-cadherin) | Adherens junction protein controlling endothelial permeability | Modulated in inflammation and tumor angiogenesis |
| PDGFRB | Pericyte receptor for PDGF-B; supports pericyte recruitment | Mutations linked to BBB dysfunction and disease |
| LAMA1/LAMB1 | Basement membrane laminins anchoring cells | Matrix remodeling affects BBB stability |
| AGER (RAGE) | Receptor for advanced glycation end products; mediates inflammatory signaling | Implicated in Alzheimer's BBB dysfunction |
| ABCB1 (P-gp) | Efflux transporter excluding xenobiotics | Key for drug delivery and barrier function |
| ABCG2 (BCRP) | Efflux transporter at the BBB | Regulates brain exposure to drugs and toxins |
| SLC2A1 (GLUT1) | Glucose transporter supplying the brain | Defects cause GLUT1 deficiency syndrome |
| SLC7A5 (LAT1) | Amino acid transporter | Maintains nutrient supply; studied in BBB models |
| MMP2/MMP9 | Matrix metalloproteinases degrading basement membrane | Inhibitors protect BBB in stroke and neuroinflammation |
| TNF | Pro-inflammatory cytokine disrupting junctions | Blockade preserves BBB in disease models |
| IL1B | Cytokine increasing permeability | Target for anti-inflammatory BBB protection |
| APOE | Lipid transport protein influencing BBB integrity | Isoform-specific effects on BBB maintenance |
| MFSD2A | Lipid transporter maintaining BBB lipid composition | Loss increases transcytosis and barrier leakage |
| PLVAP | Endothelial protein regulating transcytosis | Downregulated in mature BBB; re-expression in disease |
How Is maintenance of blood-brain barrier Regulated?
Maintenance of the blood-brain barrier is regulated by a network of signaling pathways, including Wnt/beta-catenin, PDGF-B/PDGFR-beta, angiopoietin-Tie2, and TGF-beta signaling, which control endothelial junctional gene expression and pericyte recruitment. Inflammatory pathways such as NF-kB and cytokine signaling can disrupt junctional proteins and transporters, while microglial and gut-derived signals modulate barrier properties. Metabolic regulators, including cholesterol metabolism in brain endothelial cells, have also been implicated in BBB maintenance.
maintenance of blood-brain barrier and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| APOE | Alzheimer's disease; isoform-specific BBB dysfunction | Knock-in mice expressing human APOE isoforms |
| CLDN5 | BBB leakage; neuroinflammation | Endothelial-specific knockout |
| PDGFRB | Pericyte deficiency; BBB breakdown | Point-mutation knock-in of kinase-dead allele |
| MMP9 | Stroke; basement membrane degradation | Knockout and pharmacological inhibition |
| MFSD2A | BBB lipid transport; transcytosis | Knockout and overexpression models |
Alzheimer's disease
BBB breakdown is an early feature of Alzheimer's disease and contributes to cognitive decline. Accumulation of amyloid-beta and inflammatory signaling disrupt tight junctions and transporters, impairing BBB maintenance. APOE4, a major genetic risk factor, is associated with accelerated BBB dysfunction.
Multiple sclerosis and neuroinflammation
In multiple sclerosis, immune cell infiltration across a compromised BBB is a hallmark of lesion formation. Pro-inflammatory cytokines such as TNF and IL-1beta downregulate junctional proteins and promote leukocyte transmigration, directly opposing GO:0035633.
Stroke and brain edema
Ischemic stroke triggers rapid BBB disruption through MMP activation, junctional degradation, and pericyte loss, leading to edema and hemorrhagic transformation. Preserving BBB maintenance is a therapeutic goal in stroke.
Brain tumors
Glioblastoma and other brain tumors disrupt BBB maintenance to create a leaky, immunosuppressive microenvironment. Tumor-derived factors alter junctional proteins and transporter expression, complicating drug delivery.
From maintenance of blood-brain barrier-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is gene X required for BBB maintenance? | Endothelial-specific CRISPR knockout |
| Does a disease-associated point mutation impair barrier function? | Knock-in of the point mutation in mice or human iPSC-derived BBB models |
| Can a protective variant enhance barrier integrity? | Knock-in of the variant followed by permeability assays |
| Where is the protein localized in BBB cells? | Tagged knock-in with fluorescent or epitope tag |
| Does overexpression of gene Y strengthen the barrier? | Endothelial-specific overexpression |
| Which genes modulate barrier permeability in a screen? | CRISPR library screening in brain endothelial cells |
How to Study the maintenance of blood-brain barrier Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Evans blue leakage | BBB permeability to albumin | In vivo validation of genetic models |
| RNA-seq | Transcriptional changes in BBB cells | Identify pathways altered by gene knockout |
| Proteomics | Protein abundance and modifications | Discover junctional and transporter changes |
| CRISPR library screen | Genes affecting barrier permeability | Unbiased discovery of maintenance regulators |
| Two-photon imaging | Dynamic BBB leakage and cell interactions | Live imaging in disease models |
| Electron microscopy | Ultrastructure of tight junctions | Assess junctional integrity |
| Transendothelial electrical resistance (TEER) | Barrier tightness in vitro | Evaluate BBB models and gene function |
| Single-cell RNA-seq | Cell-type-specific gene expression | Map BBB cell heterogeneity |
In vivo permeability assays
Tracer leakage assays using Evans blue, sodium fluorescein, or dextran are standard methods to assess BBB integrity in animal models. These assays quantify barrier function and are used to validate genetic models of GO:0035633.
Transcriptomic and proteomic profiling
RNA-seq and proteomics of brain endothelial cells isolated from genetic models reveal changes in junctional, transporter, and metabolic genes. These approaches identify pathways that maintain the BBB and candidate regulators.
CRISPR screening and bioinformatics
Pooled CRISPR screens in brain endothelial cells, combined with bioinformatics, can identify genes whose loss alters barrier permeability or transporter function. This unbiased approach accelerates discovery of BBB maintenance regulators.
Imaging and ultrastructure
Two-photon microscopy, electron microscopy, and super-resolution imaging visualize junctional complexes, pericyte coverage, and transcytosis in real time. These methods provide spatial and dynamic information about BBB maintenance.
How CRISPR Can Be Used to Study GO:0035633 maintenance of blood-brain barrier
Knockout
CRISPR knockout of candidate genes in brain endothelial cells or mice is used to test whether a gene is required for BBB maintenance. Endothelial-specific knockouts avoid developmental lethality and allow adult-stage analysis.
Point Mutation
Knock-in of disease-associated point mutations (e.g., in PDGFRB or APOE) models human BBB dysfunction and tests causality. Point-mutation models are valuable for studying subtle effects on barrier function.
Knock-in
Tagged knock-in of junctional or transporter proteins enables localization and interaction studies in vivo. Knock-in of reporter alleles allows lineage tracing and dynamic monitoring of BBB cells.
Overexpression
Endothelial-specific overexpression of protective genes can test whether enhancing a pathway strengthens BBB maintenance. Overexpression models complement knockout studies to establish sufficiency.
How EDITGENE Supports maintenance of blood-brain barrier Research
Researchers studying maintenance of blood-brain barrier-related genes often need to determine whether a candidate gene is causally involved in barrier integrity, how a disease-associated variant affects function, or whether enhancing a pathway can protect the BBB. EDITGENE provides end-to-end CRISPR services to answer these questions with rigor and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for maintenance of blood-brain barrier research.
Frequently Asked Questions About maintenance of blood-brain barrier
What is GO:0035633 maintenance of blood-brain barrier?
GO:0035633 is a Gene Ontology biological process term describing the preservation of the structure and regulated transport function of the blood-brain barrier, ensuring controlled movement of substances into and out of the brain.
What genes are involved in maintenance of blood-brain barrier?
Key genes include CLDN5, OCLN, TJP1, CDH5, PDGFRB, LAMA1, ABCB1, ABCG2, SLC2A1, MFSD2A, and APOE, among others.
How is the blood-brain barrier maintained?
It is maintained by continuous turnover of tight junctions, regulated transporter expression, support from pericytes and astrocytes, extracellular matrix remodeling, and controlled immune surveillance.
What happens when blood-brain barrier maintenance fails?
Failure leads to barrier leakage, neuroinflammation, edema, and neuronal dysfunction, and is implicated in Alzheimer's disease, multiple sclerosis, stroke, and brain tumors.
Are microglia required for blood-brain barrier maintenance?
Microglia are not strictly necessary for BBB maintenance in health, but they can modulate brain endothelial cholesterol metabolism.
How do researchers study maintenance of blood-brain barrier?
Common methods include in vivo permeability assays, RNA-seq, proteomics, CRISPR screens, TEER measurements, and imaging of junctional complexes.
Can CRISPR be used to study blood-brain barrier maintenance?
Yes, CRISPR knockout, point-mutation, knock-in, and overexpression models are widely used to test gene function in BBB maintenance.
What diseases are linked to blood-brain barrier maintenance?
Alzheimer's disease, multiple sclerosis, stroke, brain tumors, and sepsis-associated encephalopathy are linked to impaired BBB maintenance.
What is the role of pericytes in blood-brain barrier maintenance?
Pericytes provide structural and trophic support; their loss is associated with BBB breakdown and cognitive decline.
How does the gut-brain axis affect blood-brain barrier maintenance?
Microbiota-derived metabolites and immune signals can influence BBB integrity through the microbiota-gut-brain axis.
Conclusion
GO:0035633 maintenance of blood-brain barrier is a critical biological process that preserves CNS homeostasis by keeping the barrier structurally sound and functionally selective. Its dysregulation is a common theme in neurological disease, making it a high-priority target for mechanistic and therapeutic research. Advances in CRISPR modeling, screening, and bioinformatics now enable systematic dissection of the genes and pathways that maintain the BBB.
References
- 1. Obermeier B et al.. 2013. Development, maintenance and disruption of the blood-brain barrier.. Nat Med 19(12):1584-96 PMID: 24309662
- 2. Langen UH et al.. 2019. Development and Cell Biology of the Blood-Brain Barrier.. Annu Rev Cell Dev Biol 35:591-613 PMID: 31299172
- 3. Zhao Z et al.. 2015. Establishment and Dysfunction of the Blood-Brain Barrier.. Cell 163(5):1064-1078 PMID: 26590417
- 4. Zhao Y et al.. 2022. Factors influencing the blood-brain barrier permeability.. Brain Res 1788:147937 PMID: 35568085
- 5. Zenaro E et al.. 2017. The blood-brain barrier in Alzheimer's disease.. Neurobiol Dis 107:41-56 PMID: 27425887
- 6. Profaci CP et al.. 2024. Microglia are not necessary for maintenance of blood-brain barrier properties in health, but PLX5622 alters brain endothelial cholesterol metabolism.. Neuron 112(17):2910-2921.e7 PMID: 39142282
- 7. Ballabh P et al.. 2004. The blood-brain barrier: an overview: structure, regulation, and clinical implications.. Neurobiol Dis 16(1):1-13 PMID: 15207256
- 8. Zhuang M et al.. 2024. Microbiota-gut-brain axis: interplay between microbiota, barrier function and lymphatic system.. Gut Microbes 16(1):2387800 PMID: 39182226
